Soleno Therapeutics Inc (SLNO)

HEALTH CARE: PHARMACEUTICALS
SIC: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

1235 RADIO ROAD REDWOOD CITY, CA 94065

Soleno Therapeutics Inc operates as a pharmaceutical company.The Company develops novel therapeutic and diagnostic products for allergic rhinitis. Soleno also develops a novel diagnostic device for the detection of hemolysis.

Data as of 2021-05-08 11:38:09 -0400
Market Cap88.493 Million Shares Outstanding79.724 Million Avg 30-day Volume1.173 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-3.33 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.58847 52-week High/Low4.39 / 1.03 Next Earnings Date2021-08-09 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from SLNO instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 2 -50.0% 0 (0.0%) 1 (0.06%) -100.0%
Funds Holding: 68 67 1.49% 26 (1.56%) 26 (1.62%) 0.0%
13F shares: 44.682 Million 44.089 Million 1.34% 25.099 Million 25.351 Million -0.99%
% Ownership 56.1219 55.3779 1.34% 31.5258 31.8421 -0.99%
New Positions: 10 15 -33.33% 5 6 -16.67%
Increased Positions 22 26 -15.38% 8 7 14.29%
Closed Positions 9 13 -30.77% 5 6 -16.67%
Reduced Positions 20 11 81.82% 9 6 50.0%
Total Calls 74.914 Thousand 147.899 Thousand -49.35% 49.4 Thousand 22.6 Thousand 118.58%
Total Puts 22.136 Thousand 35.212 Thousand -37.14% 0 15.3 Thousand -100.0%
PUT/CALL Ratio 0.3 0.24 25.0% 0.0 0.68 -100.0%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding SLNO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding SLNO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MARIO ERNEST

  • Director
1,176,416 2021-04-30 6

HARRIS WILLIAM G

  • Director
79,548 2021-04-30 6

VOLCK BIRGITTE

  • Director
38,612 2021-04-30 6

ANISH BHATNAGAR CHIEF EXECUTIVE OFFICER

  • Officer
409,260 2021-01-23 4

YEN KRISTEN SEE REMARKS

  • Officer
66,492 2021-01-23 4

HIRANO PATRICIA C SEE REMARKS

  • Officer
119,104 2021-01-23 4

SINCLAIR ANDREW

  • Director
0 2021-01-08 3

MELINCOFF GWEN A

  • Director
0 2021-01-08 2

MACKANESS JAMES H CHIEF FINANCIAL OFFICER

  • Officer
0 2020-11-16 1

FEINBERG LARRY N

ORACLE PARTNERS LP

  • * SEE REMARKS* SEE REMARKS
3,660,384 2020-09-25 2

COLLINSON STUART J

  • Director
1,018 2020-07-31 1

SCHULER JACK W

  • 10% Owner
15,525,904 2020-06-26 2

ABINGWORTH LLP

  • 10% Owner
10,302,602 2020-06-26 1

VIVO VENTURES V, LLC

VIVO VENTURES FUND V, L.P.

VIVO VENTURES V AFFILIATES FUND, L.P.

  • 10% Owner
3,633,805 2019-12-02 0

BIOASIA MANGEMENT LLC

BIOASIA INVESTMENTS IV LLC

  • 10% Owner
78,798 2019-05-17 0

WOLTER JONATHAN CHIEF FINANCIAL OFFICER

WOLTER JONATHAN CHIEF FINANCIAL OFFICER

  • Officer
0 2019-01-24 0

FEINBERG LARRY N

  • 10% Owner
3,683,195 2018-12-19 2

WOLTER JONATHAN CHIEF FINANCIAL OFFICER

  • Officer
0 2018-06-15 0

DALAL RAJEN

  • Director
0 2018-06-11 0

SHAH MAHENDRA

  • Director
0 2018-06-11 0

GLASHEEN JAMES WALTER

  • Director
0 2018-06-11 0

TP MANAGEMENT VII LLC

TECHNOLOGY PARTNERS FUND VII LP

TECHNOLOGY PARTNERS AFFILIATES VII LP

  • 10% Owner
8,328,900 2018-03-07 0

ENGELSEN STEINAR J

  • Director
No longer subject to file 2018-02-05 0

ENGLEMAN EDGAR

  • Director
  • 10% Owner
No longer subject to file 2018-02-05 0

KIRNON STEPHEN

  • Director
No longer subject to file 2018-02-05 0

FEINBERG LARRY N

ORACLE PARTNERS LP

ORACLE ASSOCIATES LLC

ORACLE INVESTMENT MANAGEMENT INC

  • 10% Owner
2,388,060 2017-12-15 0

VIVO VENTURES V, LLC

  • 10% Owner
14,286,694 2017-10-02 0

O'TOOLE DAVID D

  • Director
0 2017-04-19 0

FORWARD V ASSOCIATES LLC

FORWARD VENTURES V LP

  • 10% Owner
7,173,976 2017-03-07 0

WONDKA ANTHONY SEE REMARKS

  • Officer
0 2016-06-08 0

ALEXANDER W JAMES

  • Director
No longer subject to file 2016-03-28 0

EBBERS ED SEE REMARKS

  • Officer
0 2015-05-15 0

PHELPS GINA VICE PRESIDENT OF SALES

  • Officer
0 2015-01-11 0

VIVO VENTURES FUND V, L.P.

VIVO VENTURES V AFFILIATES FUND, L.P.

VIVO VENTURES V, LLC

BDF IV ANNEX FUND LP

BIOTECHNOLOGY DEVELOPMENT FUND IV LP

BIOTECHNOLOGY DEVELOPMENT FUND IV AFFILIATES LP

BIOASIA INVESTMENTS IV LLC

BIOTECHNOLOGY DEVELOPMENT FUND II LP

BIOASIA MANGEMENT LLC

KUNG FRANK

  • 10% Owner
609,839 2014-11-18 0

VIVO VENTURES FUND V, L.P.

CHA ALBERT

ENGLEMAN EDGAR

  • Director
  • 10% Owner
609,839 2014-11-18 0

TEKNOINVEST VIII KS

TEKNOINVEST VIII B (GP) AS

TEKNOINVEST VIII GP KS

  • 10% Owner
198,565 2014-11-12 0

NABHAN ANTOUN SEE REMARKS

  • Officer
0 2014-11-12 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

VOLCK BIRGITTE - Director

2021-05-04 18:32:55 -0400 2021-04-30 A 10,537 $1.21 a 38,612 direct -6.1947 0.0 1 -6.1947 2

HARRIS WILLIAM G - Director

2021-05-04 18:36:03 -0400 2021-04-30 F 3,918 $1.21 d 79,548 direct -6.1947 0.0 1 -6.1947 2

HARRIS WILLIAM G - Director

2021-05-04 18:36:03 -0400 2021-04-30 A 12,397 a 83,466 direct -6.1947 0.0 1 -6.1947 2

MARIO ERNEST - Director

2021-05-04 18:44:08 -0400 2021-04-30 A 16,529 $1.21 a 1,176,416 direct -6.1947 0.0 1 -6.1947 2

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
SOLENO THERAPEUTICS INC SLNO 2021-05-10 22:15:04 UTC -0.9051 0.9551 500000
SOLENO THERAPEUTICS INC SLNO 2021-05-10 21:45:02 UTC -0.9051 0.9551 500000
SOLENO THERAPEUTICS INC SLNO 2021-05-10 21:15:02 UTC -0.9051 0.9551 500000
SOLENO THERAPEUTICS INC SLNO 2021-05-10 20:45:03 UTC -0.9051 0.9551 500000
SOLENO THERAPEUTICS INC SLNO 2021-05-10 20:15:03 UTC -0.9051 0.9551 500000
SOLENO THERAPEUTICS INC SLNO 2021-05-10 19:45:03 UTC -0.9051 0.9551 500000
SOLENO THERAPEUTICS INC SLNO 2021-05-10 19:15:03 UTC -0.9051 0.9551 500000
SOLENO THERAPEUTICS INC SLNO 2021-05-10 18:45:03 UTC -0.9045 0.9545 500000
SOLENO THERAPEUTICS INC SLNO 2021-05-10 18:15:03 UTC -0.9045 0.9545 500000
SOLENO THERAPEUTICS INC SLNO 2021-05-10 17:45:02 UTC -0.9045 0.9545 500000
SOLENO THERAPEUTICS INC SLNO 2021-05-10 17:15:03 UTC -0.9045 0.9545 500000
SOLENO THERAPEUTICS INC SLNO 2021-05-10 16:45:03 UTC -0.9039 0.9539 500000
SOLENO THERAPEUTICS INC SLNO 2021-05-10 16:15:03 UTC -0.9039 0.9539 500000
SOLENO THERAPEUTICS INC SLNO 2021-05-10 15:45:03 UTC -0.9039 0.9539 150000
SOLENO THERAPEUTICS INC SLNO 2021-05-10 15:15:03 UTC -0.9039 0.9539 150000
SOLENO THERAPEUTICS INC SLNO 2021-05-10 14:45:04 UTC -0.9215 0.9715 200000
SOLENO THERAPEUTICS INC SLNO 2021-05-10 14:15:04 UTC -0.9215 0.9715 200000
SOLENO THERAPEUTICS INC SLNO 2021-05-10 13:45:04 UTC -0.9215 0.9715 200000
SOLENO THERAPEUTICS INC SLNO 2021-05-10 13:15:03 UTC -0.9215 0.9715 200000
SOLENO THERAPEUTICS INC SLNO 2021-05-10 12:45:02 UTC -0.9215 0.9715 250000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments